Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference

Atherosclerosis

Volumn 241, Issue 1, 2014, Pages 264-270

  Martín, Marisa ^a   Valls, Joan ^b   Betriu, Angels ^a   Fernández, Elvira ^a   Valdivielso, Jose M ^b  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Atheromatosis; Chronic kidney disease; Phosphate; Sex differences

Indexed keywords

PHOSPHATE; PHOSPHORUS; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROMATOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHRONIC KIDNEY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; AGE; ASYMPTOMATIC DISEASE; BLOOD; CAROTID ARTERY; CAROTID ARTERY DISEASES; CLINICAL TRIAL; COMPARATIVE STUDY; ECHOGRAPHY; HEALTH DISPARITY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SPAIN; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BIOMARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHOSPHORUS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX FACTORS; SPAIN; YOUNG ADULT;

EID: 84955371069     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.02.048     Document Type: Article

References (37)

1. Santulli G. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. J. Cardiovasc. Dis. 2013, 1:1-2.
2. Vanholder R., Massy Z., Argiles A., Spasovski G., Verbeke F., Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol. Dial. Transpl. 2005, 20:1048-1056.
3. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004, 351:1296-1305.
4. Vanholder R., Massy Z., Argiles A., Spasovski G., Verbeke F., Lameire N. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol. Dial. Transpl. 2005, 20:1048-1056.
5. Betriu A., Martinez-Alonso M., Arcidiacono M.V., Cannata-Andia J., Pascual J., Valdivielso J.M., Fernandez E. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study. Nephrol. Dial. Transpl. 2014, 29:1415-1422.
6. Betriu A., Martinez-Alonso M., Arcidiacono M.V., Cannata-Andia J., Pascual J., Valdivielso J.M., Fernandez E. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study. Nephrol. Dial. Transpl. 2014, 29:1415-1422.
7. Betriu A., Martinez-Alonso M., Arcidiacono M.V., Cannata-Andia J., Pascual J., Valdivielso J.M., Fernandez E. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study. Nephrol. Dial. Transpl. 2014, 29:1415-1422.
8. Bellasi A., Mandreoli M., Baldrati L., Corradini M., Di Nicolo P., Malmusi G., Santoro A. Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin. J. Am. Soc. Nephrol. 2011, 6:883-891.
9. Foley R.N., Collins A.J., Herzog C.A., Ishani A., Kalra P.A. Serum Phosphate and Left Ventricular Hypertrophy in young adults: the coronary artery risk development in young adults study. Kidney Blood Press. Res. 2009, 32:37-44.
10. Palmer S.C., Hayen A., Macaskill P., Pellegrini F., Craig J.C., Elder G.J., Strippoli G.F.M. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease a systematic review and meta-analysis. Jama-J. Am. Med. Assoc. 2011, 305:1119-1127.
11. Ruan L.T., Chen W., Srinivasan S.R., Xu J.H., Toprak A., Berenson G.S. Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa heart study). Am. J. Cardiol. 2010, 106:793-797.
12. Chang A.R., Grams M.E. Serum phosphorus and mortality in the third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting. Am. J. Kidney Dis. 2014, 64:567-573.
13. Di Marco G.S., Konig M., Stock C., Wiesinger A., Hillebrand U., Reiermann S., Reuter S., Amler S., Kohler G., Buck F., Fobker M., Kumpers P., Oberleithner H., Hausberg M., Lang D., Pavenstadt H., Brand M. High phosphate directly affects endothelial function by downregulating annexin II. Kidney Int. 2013, 83:213-222.
14. Shuto E., Taketani Y., Tanaka R., Harada N., Isshiki M., Sato M., Nashiki K., Amo K., Yamamoto H., Higashi Y., Nakaya Y., Takeda E. Dietary phosphorus acutely impairs endothelial function. J. Am. Soc. Nephrol. 2009, 20:1504-1512.
15. Santulli G., Cipolletta E., Sorriento D., Del Giudice C., Anastasio A., Monaco S., Maione A.S., Condorelli G., Puca A., Trimarco B., Illario M., Iaccarino G. CaMK4 gene deletion induces hypertension. J. Am. Heart Assoc. 2012, 1.
16. Bozic M., Panizo S., Sevilla M.A., Riera M., Soler M.J., Pascual J., Lopez I., Freixenet M., Fernandez E., Valdivielso J.M. High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin. J. Hypertens. 2014, 32:1822-1832.
17. Ellam T.J., Chico T.J.A. Phosphate: the new cholesterol? the role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 2012, 220:310-318.
18. Eckel R.H., Jakicic J.M., Ard J.D., de Jesus J.M., Miller N.H., Hubbard V.S., Lee I.M., Lichtenstein A.H., Loria C.M., Millen B.E., Nonas C.A., Sacks F.M., Smith S.C., Svetkey L.P., Wadden T.A., Yanovski S.Z. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 2014, 63:2960-2984.
19. Onufrak S.J., Bellasi A., Cardarelli F., Vaccarino V., Muntner P., Shaw L.J., Raggi P. Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am. J. Epidemiol. 2009, 169:67-77.
20. Junyent M., Martinez M., Borras M., Coll B., Valdivielso J.M., Vidal T., Sarro F., Roig J., Craver L., Fernandez E. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study. BMC Nephrol. 2010, 11:14.
21. Junyent M., Martinez M., Borras M., Betriu A., Coll B., Craver L., Marco M.P., Sarro F., Valdivielso J.M., Fernandez E. Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: the NEFRONA project. Nefrologia 2010, 30:119-126.
22. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann. Intern Med. 1999, 130:461-470.
23. Coll B., Betriu A., Martinez-Alonso M., Amoedo M.L., Arcidiacono M.V., Borras M., Valdivielso J.M., Fernandez E. Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis. Clin. J. Am. Soc. Nephrol. 2011, 6:303-310.
24. Touboul P.J., Hennerici G., Meairs S., Adams H., Amarenco P., Desvarieux M., Ebrahim S., Fatar M., Hernandez R.H., Kownator S., Prati P., Rundek T., Taylor A., Bornstein N., Csiba L., Vicaut E., Woo K.S., Zannad F. Mannheim intima-media thickness consensus. Cerebrovasc. Dis. 2004, 18:346-349.
25. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction - the Rotterdam study. Circulation 1997, 96:1432-1437.
26. Nambi V., Chambless L., Folsom A.R., He M., Hu Y.J., Mosley T., Volcik K., Boerwinkle E., Ballantyne C.M. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk the ARIC (Atherosclerosis Risk In Communities). Study. J. Am. Coll. Cardiol. 2010, 55:1600-1607.
27. Adeseun G.A., Xie D.W., Wang X., Joffe M.M., Mohler E.R., Townsend R.R., Budoff M., Rosas S.E. Carotid Plaque, Carotid Intima-Media Thickness, and Coronary Calcification Equally discriminate prevalent cardiovascular disease in kidney disease. Am. J. Nephrol. 2012, 36:342-347.
28. Cirillo M., Ciacci C., De Santo N.G. Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N. Engl. J. Med. 2008, 359:864-866.
29. Cannata-Andia J.B., Carrillo-Lopez N., Naves-Diaz M. Estrogens and bone disease in chronic kidney disease: role of FGF23. Curr. Opin. Nephrol. Hypertens. 2010, 19:354-358.
30. Coll B., Betriu A., Martinez-Alonso M., Borras M., Craver L., Amoedo M.L., Marco M.P., Sarro F., Junyent M., Valdivielso J.M., Fernandez E. Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment. Nephrol. Dial. Transpl. 2010, 25:3017-3025.
31. Chang A.R., Grams M.E. Serum phosphorus and mortality in the third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting. Am. J. Kidney Dis. 2014, 64:567-573.
32. Saab G., Whooley M.A., Schiller N.B., Ix J.H. Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the heart and soul study. Am. J. Kidney Dis. 2010, 56:496-505.
33. Seiler S., Reichart B., Roth D., Seibert E., Fliser D., Heine G.H. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol. Dial. Transpl. 2010, 25:3983-3989.
34. Valdivielso J.M., Cannata-Andia J., Coll B., Fernandez E. A new role for vitamin D receptor activation in chronic kidney disease. Am. J. Physiol. Ren. Physiol. 2009, 297:F1502-F1509.
35. Valdivielso J.M., Coll B., Fernandez E. Vitamin D and the vasculature: can we teach an old drug new tricks?. Expert Opin. Ther. Targets 2009, 13:29-38.
36. Zoccali C., Yilmaz M.I., Mallamaci F. FGF23: a mature renal and cardiovascular risk factor?. Blood Purif. 2013, 36:52-57.
37. Cirillo M., Ciacci C., De Santo N.G. Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N. Engl. J. Med. 2008, 359:864-866.